IRIS
DE LUCA, Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.758
AS - Asia 3.059
EU - Europa 2.808
SA - Sud America 347
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 11.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.672
SG - Singapore 1.188
CN - Cina 852
UA - Ucraina 458
IE - Irlanda 438
GB - Regno Unito 370
TR - Turchia 347
RU - Federazione Russa 319
VN - Vietnam 303
SE - Svezia 289
BR - Brasile 281
IT - Italia 248
DE - Germania 230
FR - Francia 209
FI - Finlandia 131
IN - India 131
CA - Canada 54
BD - Bangladesh 50
HK - Hong Kong 33
JP - Giappone 27
AR - Argentina 24
PL - Polonia 22
MX - Messico 21
IQ - Iraq 19
KR - Corea 18
ZA - Sudafrica 18
CZ - Repubblica Ceca 17
ES - Italia 15
ID - Indonesia 15
EC - Ecuador 12
CL - Cile 11
IR - Iran 10
BE - Belgio 9
CH - Svizzera 9
EU - Europa 9
LT - Lituania 9
NL - Olanda 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
IL - Israele 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AT - Austria 6
CO - Colombia 6
PK - Pakistan 6
RS - Serbia 6
TN - Tunisia 6
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
EG - Egitto 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
NP - Nepal 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
MK - Macedonia 2
NI - Nicaragua 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
SY - Repubblica araba siriana 2
AL - Albania 1
BW - Botswana 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
PR - Porto Rico 1
PY - Paraguay 1
SR - Suriname 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.033
Salva come PNG Salva come JPEG
Città #
Singapore 880
San Jose 528
Jacksonville 511
Chandler 508
Dublin 433
Dallas 357
Ashburn 309
Southend 258
Beijing 216
Izmir 192
Princeton 188
Nanjing 152
Council Bluffs 144
Wilmington 130
Los Angeles 115
Santa Clara 109
The Dalles 100
Ho Chi Minh City 89
Cambridge 84
Dearborn 84
New York 84
Hanoi 62
Munich 61
Tongling 59
Nanchang 58
Woodbridge 52
Ann Arbor 51
Altamura 45
Buffalo 42
Moscow 41
Chieti 34
Dong Ket 33
Houston 31
São Paulo 31
Hefei 30
Hong Kong 29
Jiaxing 29
Helsinki 27
Redondo Beach 26
Boardman 25
Shenyang 25
Montreal 24
Norwalk 24
Tokyo 23
Frankfurt am Main 22
Tianjin 20
Turku 20
Brooklyn 19
Grevenbroich 19
Kunming 19
Warsaw 19
London 18
Orem 18
Seoul 17
Washington 17
Hebei 16
Da Nang 15
Denver 15
Stockholm 15
Atlanta 14
Johannesburg 14
Toronto 14
Mexico City 13
Brno 12
Changsha 12
Hangzhou 12
Leawood 12
San Francisco 12
San Mateo 12
Chennai 11
Chicago 11
Phoenix 11
Ardabil 10
Baghdad 10
Nuremberg 10
Poplar 10
Rio de Janeiro 10
Rome 10
Augusta 9
Cedar Knolls 9
Haiphong 9
Jinan 9
Mumbai 9
Torino 9
Amsterdam 8
Biên Hòa 8
Boston 8
Brussels 8
Guangzhou 8
Lanzhou 8
Manchester 8
Pescara 8
Teramo 8
Campobasso 7
Can Tho 7
Monmouth Junction 7
Tashkent 7
Ankara 6
Belgrade 6
Brasília 6
Totale 6.994
Salva come PNG Salva come JPEG
Nome #
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 188
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 178
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 167
IL 13 in multiple sclerosis 166
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 164
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 158
Increasing age at disability milestones among MS patients in the MSBase Registry 153
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 150
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 149
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 148
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 147
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 145
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 142
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 142
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 141
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 141
Effect of TNF intraneural injection into the rat sciatic nerve 137
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 137
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 136
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 136
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 136
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 134
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 134
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 133
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 132
CD1A and CD1E gene polymorphisms are associated withsusceptibility to multiple sclerosis 128
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy 128
Effect of rhTNF-alpha injection into rat sciatic nerve 127
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 126
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 125
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 125
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 124
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 123
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 123
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 122
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 121
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 121
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 121
JCV-Ab serostatus in MS patients treated with Natalizumab 121
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 120
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 119
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 118
Effect of rhTNF-a injection into rat sciatic nerve 118
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 118
Nail loss after teriflunomide treatment: a new potential adverse event 117
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 116
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 116
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 116
Serum soluble adhesion molecules and proinflammatory cytokines are not increased in chronic inflammatory demyelinating polyneuropathy 114
Interferon beta1b: the Chieti experience 113
Interferon beta normalizes suppressor cell function in dysimmune neuropathies. 112
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 111
Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases 111
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 109
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 109
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 107
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 107
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 106
A Multicentre italian study on efficacy and safety of Glatiramer Acetate in multiple sclerosis patients with allergic respiratory diseases 106
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 104
Suppressor cell function is decreased in chronic inflammatory demyelinating polyneuropathy 103
Mononeuropathy following subcutaneous interferon-β injection 102
Livelli sierici e liquorali di IL13 nella Sclerosi Multipla 101
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis 100
Interferon β 1b: The Chieti experience 97
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register 97
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 96
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 96
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 96
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 96
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 96
Effects of IFN-Beta on rantes and MCP-1 secretion by mononuclear cells frm patients with multiple sclerosis 95
Epilepsy and multiple sclerosis: Clinical, radiological, electrophysiological and neuropsychological aspects 94
IL-13 levels in serum and cerebro-spinal fluid of multiple sclerosis patients 93
Evaluation of suppressor cell function in chronicn inflammatory demyelinating polyneuropathy (CIDP) 93
Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica. 93
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 93
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 92
Pregnancy and fetal outcomes after paternal exposure to disease modifying drugs for multiple sclerosis 92
Interferone beta1b: bilancio su un gruppo di 30 pazienti 90
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis 89
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society 86
Pregnancy And Fetal Outcomes After Paternal Exposure To Disease Modifying Drugs For Multiple Sclerosis (P4.157) 86
Non-neuronal acetylcholine: a new modulator of immune responses in multiple sclerosis patients. 85
Modulation of the immune response in multiple sclerosis patients: effect of non-neuronal acetylcholine 84
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs 84
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 83
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients. 82
Progressive multifocal leukoencephalopathy or severe multiple sclerosis relapse following COVID-19 vaccine: a diagnostic challenge 81
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 81
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 78
Gestione degli effetti indesiderati della terapia con interferone beta nella sclerosi multipla 78
Efficacy and safety of glatiramer acetate in multiple sclerosis patients with allergicrespiratory diseases. 78
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 77
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 76
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 75
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 68
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 32
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod 31
Epilepsy in MS and its association with cognitive and psychological burden 14
Totale 11.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/2022357 2 4 6 57 11 11 16 34 32 7 54 123
2022/20231.321 104 152 72 158 143 272 81 93 171 17 29 29
2023/2024653 46 30 38 16 37 225 145 30 0 31 5 50
2024/20251.766 117 317 334 26 34 65 42 59 123 94 230 325
2025/20263.777 334 144 500 492 363 204 598 189 391 283 201 78
Totale 11.177